Cart Icon0
Menu

Search from website

Mouse mAb to HIV-1 p24 (clone N17)

 

Figure 1: Western Blot testing of HIV-1 p24 antibody, clone N17. Line 1. HIV-1 Gag p17/24 (Han-2 subtype) Line 2. Protein size marker.

(for reference only; data shown are from a single production batch at release and may not be representative of other batches)

Select volume:

Quantity:

Catalogue #

A2-854-100

Name

Mouse mAb to HIV-1 p24 (clone N17)

Description

The epitope for clone N17 corresponds to the following amino acid (aa) positions in the HIV-1 p24 protein sequence: C-terminus (165-231).

Target

HIV-1 p24

Target Description

Recombinant p24 protein of HIV-1 B-subtype consensus produced in E. coli

Clonality

Mouse monoclonal

Clone

N17

Class

mIgG1

Reactivity

Reacts with HIV-1 p24 subtype B, C and A.

Application

ELISA, WB, CLIA

Protocol

Monoclonal antibody working titer has to be established practically for each particular antigen and assay format

Buffer

PBS pH 7.4, with 0.1 % sodium azide

Related Products

HIV-1 p24 antibody clone N17 has been identified as a recommended capture antibody with clones 2N32 (cat# A2-859-100) and 2N34 (cat# A2-858-100).

Shipping

Shipping in ambient conditions.

Storage

Store at -20 °C to -70 °C. Avoid multiple freeze-thaw cycles.

Background

HIV-1 p24 is a crucial protein component of the human immunodeficiency virus type 1 (HIV-1), the virus responsible for causing acquired immunodeficiency syndrome (AIDS). It is encoded by the Gag gene and serves as a fundamental building block for the viral core capsid. Due to its consistent presence in HIV-1, p24 has become an essential diagnostic marker for detecting HIV infection. Diagnostic tests, such as enzyme-linked immunosorbent assays (ELISAs) and rapid antibody tests, are specifically designed to detect antibodies that the patient's immune system produces in response to HIV-1 p24 protein. This antibody detection is a crucial step in diagnosing HIV infection. However, in the early stages of HIV infection, when the patient's immune response is still developing and antibodies may not be present in sufficient quantities for detection, the direct detection of p24 antigen in the bloodstream becomes exceptionally valuable. The current recommendations advocate the use of antibody-antigen assays, which can detect p24 and the antibody response to the virus. These assays are favoured for HIV screening due to their capability to shorten the time between infection and a positive HIV test result to less than one month.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart